ADVANCED BILE DUCT CARCINOMA
Clinical trials for ADVANCED BILE DUCT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILE DUCT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILE DUCT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug combo enters first human safety tests
Disease control OngoingThis is an early-stage safety study testing a new drug called BAY 1895344 when given with standard chemotherapy drugs (cisplatin with or without gemcitabine). The main goals are to find the safest dose and understand the side effects in people with advanced solid tumors that have…
Matched conditions: ADVANCED BILE DUCT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New pill aims to supercharge radiation against tough cancers
Disease control OngoingThis early-stage study is testing a new oral drug called ropidoxuridine (IPdR) in patients with advanced gastrointestinal cancers that have spread. The main goal is to find the safest dose of the drug when taken daily alongside standard radiation therapy. Researchers hope the dru…
Matched conditions: ADVANCED BILE DUCT CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC